Targeted Desialylation Overcomes Glyco-Immune Checkpoints and Potentiates the Anticancer Immune Response in Vivo
doi 10.26434/chemrxiv.8187146.v1
Full Text
Open PDFAbstract
Available in full text
Date
May 28, 2019
Authors
Publisher
American Chemical Society (ACS)